4.8 Article

USP38 Inhibits Type I Interferon Signaling by Editing TBK1 Ubiquitination through NLRP4 Signalosome

期刊

MOLECULAR CELL
卷 64, 期 2, 页码 267-281

出版社

CELL PRESS
DOI: 10.1016/j.molcel.2016.08.029

关键词

-

资金

  1. National Key Basic Research Program of China [2014CB910800, 2015CB859800]
  2. National Natural Science Foundation of China [31370869, 31522018]
  3. Guangdong Natural Science Funds for Distinguished Young Scholar [S2013050014772]
  4. Guangdong Innovative Research Team Program [2011Y035, 201001Y0104687244]
  5. National Cancer Institute (NCI) [CA101795, DA030338]
  6. National Institute on Drug Abuse (NIDA), NIH

向作者/读者索取更多资源

TBK1 is a component of the type I interferon (IFN) signaling pathway, yet the mechanisms controlling its activity and degradation remain poorly understood. Here we report that USP38 negatively regulates type I IFN signaling by targeting the active form of TBK1 for degradation in vitro and in vivo. USP38 specifically cleaves K33-linked poly-ubiquitin chains from TBK1 at Lys670, and it allows for subsequent K48-linked ubiquitination at the same position mediated by DTX4 and TRIP. Knockdown or knockout of USP38 increases K33-linked ubiquitination, but it abrogates K48-linked ubiquitination and degradation of TBK1, thus enhancing type I IFN signaling. Our findings identify an essential role for USP38 in negatively regulating type I IFN signaling, and they provide insights into the mechanisms by which USP38 regulates TBK1 ubiquitination through the NLRP4 signalosome.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据